Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 220,899,194 papers from all fields of science
Search
Sign In
Create Free Account
SGI 1776
Known as:
SGI-1776
, SGI1776
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Imidazoles
Pyridazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Anti‐tumour effects of PIM kinase inhibition on progression and chemoresistance of hepatocellular carcinoma
M. Leung
,
Kristy Kwan-Shuen Chan
,
+8 authors
R. Lo
Journal of Pathology
2020
Corpus ID: 219910941
Hepatocellular carcinoma (HCC) is a biologically aggressive cancer. Targeted therapy is in need to tackle challenges in the…
Expand
2019
2019
Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis.
J. Remy
,
B. Linder
,
+4 authors
D. Kögel
Biochimica et biophysica acta. Molecular cell…
2019
Corpus ID: 53248218
2016
2016
Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition
A. Iqbal
,
F. Eckerdt
,
+6 authors
L. Platanias
OncoTarget
2016
Corpus ID: 4779901
The PIM family of proteins encodes serine/threonine kinases with important roles in protein synthesis and cancer cell metabolism…
Expand
2015
2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemias
D. A. Curi
,
Elspeth M Beauchamp
,
+5 authors
L. Platanias
OncoTarget
2015
Corpus ID: 17981018
We investigated the efficacy of targeting the PIM kinase pathway in Philadelphia chromosome-positive (Ph+) leukemias. We provide…
Expand
2013
2013
Biological effects of the Pim kinase inhibitor, SGI-1776, in multiple myeloma.
F. Cervantes-Gomez
,
Lisa S. Chen
,
R. Orlowski
,
V. Gandhi
Clinical Lymphoma, Myeloma & Leukemia
2013
Corpus ID: 23463967
2012
2012
Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity.
Deanne C. Tibbitts
,
Julie R Escamilla-Powers
,
Xiao-li Zhang
,
R. Sears
Blood
2012
Corpus ID: 206910008
To the editor: A recent article in Blood demonstrated that the Pim kinase inhibitor SGI-1776 has efficacy in acute myeloid…
Expand
2011
2011
PIM kinase isoform specific regulation of MIG6 expression and EGFR signaling in prostate cancer cells
Allan Siu
,
C. Virtanen
,
J. Jongstra
OncoTarget
2011
Corpus ID: 12080628
The PIM family of oncogenic serine/threonine kinases regulates tumour cell proliferation. To identify proliferative signaling…
Expand
2011
2011
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
D. Mahalingam
,
C. Espitia
,
+8 authors
S. Nawrocki
British Journal of Cancer
2011
Corpus ID: 4553769
Background:Upregulation of PIM kinase expression has been reported in many malignancies, suggesting that inhibition of PIM kinase…
Expand
2009
2009
Synergistic Activity of Co-Treatment with PIM1 Kinase Inhibitor SGI-1776 and Histone Deacetylase Inhibitor Panobinostat or Heat Shock Protein 90 Inhibitor AUY922 against Human CML and…
W. Fiskus
,
K. Buckley
,
+8 authors
K. Bhalla
2009
Corpus ID: 89709003
Abstract 2651 Poster Board II-627 The oncoprotein PIM1 is a cytoplasmic serine/threonine kinase, which is overexpressed and…
Expand
2008
2008
Progress in Applying HPC to Support Operational Use of CT-Analyst
G. Patnaik
,
J. Boris
,
K. Obenschain
,
R. Rosenberg
,
W. Anderson
,
M. Xu
DoD HPCMP Users Group Conference
2008
Corpus ID: 44875069
The objective of this effort is to perform the research and development (R&D) and systems engineering necessary to integrate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required